| Dronedarone impurity A | 141626-35-9 | C27H36N2O5S |
| Dronedarone impurity A CRS | 197431-02-0 | C27H37ClN2O5S |
| Dronedarone impurity A CRS | 197431-02-0 | C27H37ClN2O5S |
| Dronedarone impurity B | 141626-57-5 | C32H46N2O7S2 |
| Dronedarone impurity B | 141644-91-9 | C30H42N2O3 |
| Dronedarone Intermediate 4 | 36421-15-5 | C11H24ClN |
| Dronedarone Intermediate 5 | 115555-77-6 | C11H25Cl2N |
| Dronedarone Intermediate 6 | 133238-87-6 | C12H13NO3 |
| Dronedarone Intermediate 7 | 141645-20-7 | C18H15NO5 |
| Dronedarone N-Oxide | 1638586-56-7 | C31H44N2O6S |
| Dronedarone Related Compound 1 | 335153-23-6 | C14H17NO6 |
| Dronedarone Related Compound A | 197431-02-0 | C27H37ClN2O5S |
| Dronedarone USP Related Compound B | 500791-70-8 | C32H44N2O7 |
| Dronedarone USP Related Compound C | 1278585-68-4 | C19H19NO3 |
| Dronedarone USP Related Compound D | 141645-16-1 | C19H17NO5 |
| Dronedarone-D6 | 1132693-87-8 | C31H44N2O5S |
| Droperidol EP Impurity A | 2147-83-3 | C12H13N3O |
| Droperidol EP Impurity B | 1026015-45-1 | C22H22FN3O2 |
| Droperidol EP Impurity C | 60373-76-4 | C22H19ClFN3O2 |
| Droperidol EP Impurity D | 466118-75-2 | C22H22FN3O3 |
| Droperidol EP Impurity E | 1346604-17-8 | C34H34N6O3 |
| Droperidol Imp. A (EP): 1-(1,2,3,6-Tetrahydropyridin- 4-yl)-1,3-dihydro-2H-benzimidazol-2-one | 2147-83-3 | C12H13N3O |
| Droperidol Imp. C (EP): 1-[4-(4-Fluorophenyl)-4-oxo-butyl]-4-(2-oxo-2,3- dihydro-1H-benzimidazol-1-yl)pyridinium Chloride | 60373-76-4 | C22H19ClFN3O2 |
| Droperidol Impurity 9 | 25551-59-1 | C11H9N3O2 |
| Droperidol Impurity 10 | 65053-26-1 | C11H11N3 |
| Drospirenone EP Impurity A | 67372-68-3 | C23H30O3 |
| Drospirenone EP Impurity B | Not available | C24H32O4 |
| Drospirenone EP Impurity C | 116298-21-6 | C21H26O2 |
| Drospirenone EP Impurity D | 67372-69-4 | C23H28O3 |
| Drospirenone EP Impurity E | 90457-65-1 | C24H30O3 |
| Drospirenone EP Impurity F | Not available | C24H32O3 |
| Drospirenone EP Impurity G | 932388-90-4 | C24H31ClO3 |
| Drospirenone EP Impurity H | 932388-89-1 | C24H31ClO3 |
| Drospirenone EP Impurity I | 2896199-04-3 | C24H32O3 |
| Drospirenone for peak identification | 67392-87-4 | C24H30O3 |
| Drospirenone Impurity 15 | 82543-16-6 | C21H30O3 |
| Drospirenone Impurity 21 | 82543-15-5 | C20H28O3 |
| Drospirenone Impurity 23 | 863329-71-9 | C24H32O3 |
| Drospirenone Impurity 26 | 82543-17-7 | C24H34O4 |
| Drospirenone impurity E | 90457-65-1 | C24H30O3 |
| Drospirenone Related Compound A | 90457-65-1 | C24H30O3 |
| Drotaverin | 14009-24-6 | C24H31NO4 |
| Drotaverine (Hydrochloride) | Not available | C24H32ClNO4 |
| Drotaverine amide | 6298-46-0 | C24H33NO5 |
| Drotaverine Impurity 1 | 38464-04-9 | C12H16O4 |
| Drotaverine Impurity 2 | 61381-04-2 | C12H19NO2 |
| Drotaverine Impurity 3 | 85475-88-3 | C22H27NO4 |
| Drotaverine Impurity 4 | 27472-21-5 | C12H15NO2 |
| Drotaverine Impurity 4 (Hydrochloride) | 85475-87-2 | C22H28ClNO4 |
| Drotaverine Impurity 11 | 92157-09-0 | C13H18O4 |
| Drotaverine Impurity 12 | 69373-87-1 | C14H20O4 |
| Drotaverine Impurity 14 | 526190-09-0 | C12H17NO3 |
| Drotaverine Impurity 15 | 37491-68-2 | C7H9NO2 |
| Drotaverine Impurity 16 | 2050-46-6 | C10H14O2 |
| Drotaverine Impurity 17 | 27472-20-4 | C11H15ClO2 |
| Drotaverine Impurity 19 | 2754344-55-1 | C24H31NO5 |
| Drotaverine Impurity 21 | Not available | C22H28ClNO4 |
| Drotaverine Impurity 22 | Not available | C22H28ClNO4 |
| Drotaverine Impurity 23 | Not available | C22H28ClNO4 |
| Drotaverine Impurity 25 | Not available | C20H24ClNO4 |
| Drotaverine Impurity 29 | 869942-88-1 | C11H17NO2 |
| Drotaverine Impurity 30 | 56046-20-9 | C24H27NO5 |
| Drotaverine Impurity 31 | 75500-95-7 | C22H27NO4 |
| Drotaverine Intermediate 1 | 71457-14-2 | C24H33NO5 |
| Droxidopa | 23651-95-8 | C9H11NO5 |
| Droxidopa impurity 1 | 16322-99-9 | C9H11NO5 |
| Droxidopa Impurity 1 | 13023-73-9 | C8H8O4 |
| Droxidopa Impurity 2 | 5707-55-1 | C8H8O3 |
| Droxidopa Impurity 4 | 55382-14-4 | C31H29NO7 |
| Droxidopa Impurity 6 | 90044-46-5 | C16H15NO4 |
| Droxidopa Impurity 7 | 28865-97-6 | C10H13NO5 |
| Droxidopa Impurity 8 | 34047-62-6 | C9H11NO5 |
| Droxidopa Impurity 10 | 88375-62-6 | C10H11NO5 |
| Droxidopa Impurity 11 | 524-38-9 | C8H5NO3 |
| Droxidopa Impurity 13 | 96561-53-4 | C17H13NO7 |
| Droxidopa Impurity 14 | 3916-18-5 | C9H11NO5 |
| Duetasteride EP impurity B | 2512195-98-9 | C21H32N2O2 |
| Duetasteride EP impurity C | 157307-36-3 | C21H31NO3 |
| Duetasteride EP impurity G | 1430804-85-5 | C27H28F6N2O2 |
| Duetasteride impurity 5 | 2102935-76-0 | C27H30F6N2O2 |
| Duetasteride impurity 7 | 164656-22-8 | C27H32F6N2O2 |
| Duloxetine EP impurity B | 116539-55-0 | C8H13NOS |
| Duloxetine EP Impurity C | 949096-01-9 | C18H20BrNOS |
| Duloxetine EP impurity C | 949095-98-1 | C18H19NOS |
| Duloxetine EP impurity E | 1033803-59-6 | C18H19NOS |
| Duloxetine for system suitability | 136434-34-9 | C18H20ClNOS |
| Duloxetine Hydrochloride Imp. A (EP) as Hydrochloride: (3R)-N-Methyl-3-(naphthalen-1- yloxy)-3-(thiophen-2-yl)propan-1-amine Hydrochloride ((R)- Duloxetine Hydrochloride) | 910138-96-4 | C18H20ClNOS |
| Duloxetine Hydrochloride Imp. B (EP): (1S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol | 116539-55-0 | C8H13NOS |
| Duloxetine Hydrochloride Imp. C (EP): 4-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl] | 949095-98-1 | C18H19NOS |
| Duloxetine Hydrochloride Imp. D (EP): Naphthalen-1-ol (1-Naphthol) | 90-15-3 | C10H8O |
| Duloxetine impurity 8 | 132335-46-7 | C19H21NOS |
| Duloxetine Impurity 8 (Oxalicacid) | 132335-47-8 | C21H23NO5S |
| Duloxetine impurity 9 (Oxalate) | 932013-45-1 | C21H23NO5S |
| Duloxetine impurity 12 | 199191-66-7 | C22H23NO4S |
| Duloxetine impurity 13 | 199191-67-8 | C26H23NO4S |
| Duloxetine impurity 14 | 116539-57-2 | C8H13NOS |
| Duloxetine impurity 15 | 5424-47-5 | C9H14ClNOS |
| Duloxetine impurity 16 | 13636-02-7 | C9H15NOS |
| Duloxetine impurity 17 | 132335-44-5 | C9H15NOS |
| Duloxetine impurity 20 | 164071-61-8 | C17H15ClOS |
| Duloxetine Impurity 20 | 116817-27-7 | C18H19NOS |
| Duloxetine Impurity 21 | 116817-25-5 | C19H21NOS |
| Duloxetine Impurity 21 (Oxalicacid) | 116817-26-6 | C21H23NO5S |
| Duloxetine Impurity 22 | 5234-06-0 | C13H12O2 |
| Duloxetine Impurity 22 | 132335-49-0 | C9H15NOS |
| Duloxetine impurity A | 116539-60-7 | C18H19NOS |
| Duloxetine impurity A | 910138-96-4 | C18H20ClNOS |
| Duloxetine impurity D | 90-15-3 | C10H8O |
| Duloxetine impurity G | 321-38-0 | C10H7F |
| Duloxetine Related Compound A | 910138-96-4 | C18H20ClNOS |
| Duloxetine Related Compound F | 1104890-90-5 | C18H20ClNOS |
| Duloxetine Related Compound H | 199191-66-7 | C22H23NO4S |
| Dutasteride Beta-Dimer | 1648593-70-7 | C46H55F6N3O4 |
| Dutasteride EP Impurity A | 104239-97-6 | C19H27NO3 |
| Dutasteride for system suitability | 164656-23-9 | C27H30F6N2O2 |
| Dutasteride Impurity C | Not available | C21H31NO3 |
| Dutasteride Impurity E | 1796930-46-5 | C27H30F6N2O2 |
| Dutasteride Impurity F | Not available | C27H31ClF6N2O2 |
| Dutasteride Impurity I | 1648593-70-7 | C46H55F6N3O4 |
| Duvelisib | 1201438-56-3 | C22H17ClN6O |
| Duvelisib (R-enantiomer) | 1261590-48-0 | C22H17ClN6O |
| Duvelisib Impurity 1 | 146553-06-2 | C10H20N2O4 |
| Duvelisib Impurity 2 | 6833-13-2 | C13H10ClNO |
| Duvelisib Intermediate 1 | 2199389-46-1 | C17H15ClN2O |
| Duvelisib Intermediate 2 | 1350643-72-9 | C17H15ClN2O |
| Duvelisib Related Compound 1 | 1386861-46-6 | C14H12ClNO |
| Dyclonine | 586-60-7 | C18H27NO2 |
| Dyclonine Impurity 1 | 95605-38-2 | C9H8O2 |
| Dyclonine Impurity 2 | 66536-15-0 | C13H16O2 |
| Dyclonine Impurity 3 | 14146-86-2 | C24H28O4 |
| Dyclonine Impurity 4 | 2835362-80-4 | C15H20O4 |
| Dyclonine Impurity 5 | 165261-15-4 | C13H18O3 |
| Dyclonine Impurity 6 (Hydrochloride) | 80840-88-6 | C9H20ClN |
| Dyclonine Impurity 7 | 50743-14-1 | C12H16O2 |
| Dyclonine Impurity 8 | 61405-66-1 | C12H16O2 |
| Dyclonine Impurity 11 | 7197-02-6 | C12H16O2 |
| Dyclonine Impurity 11 | 3180-09-4 | C10H14O |
| Dyclonine Impurity 12 | 37062-67-2 | C12H16O2 |
| Dyclonine Impurity 12 | 5249-96-7 | C18H28ClNO2 |
| Dyclonine Impurity 13 | 28066-70-8 | C14H22O |
| Dyclonine Impurity 14 | 80919-64-8 | C13H17ClO2 |
| Dydrogesteron | 152-62-5 | C21H28O2 |
| Dydrogesterone EP Impurity A | 23035-53-2 | C21H26O2 |
| Dydrogesterone EP Impurity B | 1162-56-7 | C21H28O2 |
| Dydrogesterone EP Impurity C | 246038-13-1 | C21H28O2 |
| Dydrogesterone Imp. B (EP): Pregna-4,6-diene-3,20-dione ( 6-Progesterone) | 1162-56-7 | C21H28O2 |
| Dydrogesterone Impurity 3 | 25093-47-4 | C21H28O2 |
| Dydrogesterone Impurity 4 | 19592-55-3 | C25H36O4 |
| Dydrogesterone Impurity 5 | 5488-51-7 | C25H36O4 |
| Dydrogesterone Impurity 8 (Progesterone Impurity 17) | 652-69-7 | C21H32O3 |
| Dydrogesterone Impurity 10 | 4243-74-7 | C21H30O2 |
| Dydrogesterone Impurity 11 | 4243-73-6 | C21H30O2 |
| Dydrogesterone Impurity 12 | 86495-64-9 | C21H30O2 |
| Dydrogesterone Impurity 16 | 2640-38-2 | C21H28O2 |
| Dydrogesterone Impurity 18 | 99958-08-4 | C25H36O4 |
| Dydrogesterone Impurity 19 | 151478-10-3 | C25H36O4 |
| Dydrogesterone impurity A | 23035-53-2 | C21H26O2 |
| Dydrogesterone impurity B | 1162-56-7 | C21H28O2 |
| E1 Colistimethate sodium for peak identification | 8068-28-8 | C58H105N16Na5O28S5 |
| E1 Colistimethate sodium for peak identification | 8068-28-8 | C58H105N16Na5O28S5 |
| E2 Colistimethate sodium for peak identification | 8068-28-8 | C58H105N16Na5O28S5 |
| E2 Colistimethate sodium for peak identification | 8068-28-8 | C58H105N16Na5O28S5 |
| E)-N-(3-((2-Chlorothiazol-5-yl)methyl)-5-methyl-1,3,5-oxadiazinan-4-ylidene)benzenesulfonamide | Not available | C14H15ClN4O3S2 |
| E-Cefodizime impurity | 97180-26-2 | C20H20N6O7S4 |
| E-Cilastatin Acid | 78852-98-9 | C16H26N2O5S |
| E-Ospemifene | 238089-02-6 | C24H23ClO2 |
| Ebastine EP Impurity B | 943-27-1 | C12H16O |
| Ebastine EP Impurity C | 58258-01-8 | C18H21NO |
| Ebastine EP Impurity C Hydrochloride | 65214-86-0 | C18H22ClNO |
| Ebastine EP Impurity D | 97928-18-2 | C19H29NO2 |
| Ebastine EP Impurity E | 1312211-93-0 | C33H41NO2 |
| Ebastine EP Impurity F | 1429071-63-5 | C32H39NO3 |
| Ebastine EP Impurity G | 1429071-65-7 | C32H39NO3 |
| Ebastine Imp. A (EP): Diphenylmethanol (Benzhydrol) | 91-01-0 | C13H12O |
| Ebastine Imp. B (EP): 1-[4-(1,1-Dimethylethyl)phenyl]- ethanone | 943-27-1 | C12H16O |
| Ebastine Imp. C (EP) as Hydrochloride: 4-(Diphenyl- methoxy)piperidine Hydrochloride | 65214-86-0 | C18H22ClNO |
| Ebastine Imp. D (EP): 1-[4-(1,1-Dimethylethyl)phenyl]- 4-(4-hydroxypiperidin-1-yl)butan-1-one | 97928-18-2 | C19H29NO2 |
| Ebastine Impurity 9 | 1229622-28-9 | C14H20O2 |
| Ebastine Impurity 10 | 59477-80-4 | C14H20O |
| Ebastine N-Oxide (cis and trans) | 1256285-71-8 | C32H39NO3 |
| Ebastine N-Oxide (Mixture of cis- and trans-isomers) | 1256285-71-8 | C32H39NO3 |
| Ebastine Related Compound C (4- (diphenylmethoxy)piperidine hydrochloride) | Not available | C18H22ClNO |
| Ecabet Sodium | 86408-72-2 | C20H27NaO5S |
| Ecgonine Ethyl Ester | 70939-97-8 | C11H19NO3 |
| Ecgonine HCl | 5796-31-6 | C9H16ClNO3 |
| Ecgonine Hydrochloride | 5796-31-6 | C9H16ClNO3 |
| Econazole (Miconazole nitrate EP impurity B) | 27220-47-9 | C18H15Cl3N2O |
| Econazole EP Impurity A | 24155-42-8 | C11H10Cl2N2O |
| Econazole EP impurity B | 2334059-11-7 | C15H14Cl3NO |
| Econazole EP Impurity C | Not available | C25H21Cl5N2O |
| Econazole for system suitability | 68797-31-9 | C18H16Cl3N3O4 |
| Econazole for system suitability | 24169-02-6 | C18H16Cl3N3O4 |
| Econazole Impurity 1 | 137958-96-4 | C8H6Cl2O2 |
| Econazole Impurity 2 | 81547-71-9 | C8H5Cl3O |
| Econazole Impurity 3 | 116865-83-9 | C8H5Cl3O |
| Econazole Impurity 4 | 45892-47-5 | C8H5Cl3 |
| Econazole Impurity 5 | 13692-15-4 | C8H6Cl2O |
| Econazole Impurity 6 | 88965-93-9 | C8H9Cl2NO |
| Econazole Impurity D | 24168-96-5 | C18H15Cl4N3O4 |
| Econazole Nitrate Imp. A (EP): (1RS)-1-(2,4- Dichlorophenyl)-2-(1H-imidazol-1-yl)- ethanol | 24155-42-8 | C11H10Cl2N2O |
| Econazole Related Compound A | 24155-42-8 | C11H10Cl2N2O |
| Ecrita impurity 1 | 143664-11-3 | C34H33N3O5 |
| Edaravone (5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one) | 89-25-8 | C10H10N2O |
| Edaravone Impurity 1 | 177415-76-8 | C20H18N4O2 |
| Edaravone Impurity 2 | 124009-63-8 | C30H26N6O3 |
| Edaravone Impurity 3 | 300543-31-1 | C12H14N2O |
| Edaravone Impurity 4 | 1016-41-7 | C12H14N2O |
| Edaravone impurity B | 68195-63-1 | C30H26N6O3 |
| Edaravone impurity DO | 5393-61-3 | C10H10N2O2 |
| Edaravone impurity EPH | 6078-46-2 | C12H16N2O2 |
| Edaravone impurity HPO | 152494-76-3 | C10H10N2O2 |
| Edaravone impurity P1 | 1357477-99-6 | C13H14N2O6S |
| Edaravone impurity P3 | 1323485-71-7 | C13H16N2O4S |
| Edaravone Impurity P4 | 1242471-40-4 | C13H16N2O5S |
| Edaravone impurity PBH | 710307-89-4 | C10H12N2O2 |
| Edevoxetine hydrochloride | 1194374-05-4 | C18H27ClFNO4 |
| Edoxaban (1R,2R,4R) Isomer | 1255529-24-8 | C24H30ClN7O4S |
| Edoxaban (1R,2R,4R) Isomer (4-Methylbenzenesulfonate) | 2852734-46-2 | C31H38ClN7O7S2 |
| Edoxaban (1R,2R,4S) Isomer | 500572-10-1 | C24H30ClN7O4S |
| Edoxaban (1R,2R,4S) Isomer (4-Methylbenzenesulfonate) | 2605225-71-4 | C31H38ClN7O7S2 |
| Edoxaban (1R,2S,4S) Isomer | 1255529-25-9 | C24H30ClN7O4S |
| Edoxaban EP Impurity C | 1255529-27-1 | C24H30ClN7O4S |
| Edoxaban EP Impurity G | 1255529-26-0 | C24H30ClN7O4S |
| Edoxaban EP Impurity H | 1255529-28-2 | C24H30ClN7O4S |
| Edoxaban Impurity 1 (Oxalate Monohydrate) | 1353893-22-7 | C16H31N3O8 |
| Edoxaban Impurity 2 | 720720-96-7 | C8H11ClN2O2S |
| Edoxaban Impurity 3 | 1243308-37-3 | C9H10Cl2N2O3 |
| Edoxaban Impurity 4 | 480452-36-6 | C21H30ClN5O5 |
| Edoxaban Impurity 5 | 2568974-02-5 | C23H25Cl2N7O5 |
| Edoxaban Impurity 9 | 2024614-15-9 | C21H30ClN5O5 |
| Edoxaban Impurity 11 | 480451-98-7 | C21H30ClN5O5 |
| Edoxaban Impurity 13 | 767625-11-6 | C19H27N5O5S |
| Edoxaban Impurity 14 | Not available | C24H30ClN7O5S |
| Edoxaban Impurity 19 | 834919-19-6 | C22H25ClN6O5S |
| Edoxaban Impurity 20 | 929693-30-1 | C14H26N2O4 |
| Edoxaban Impurity 21 | 929693-31-2 | C15H28N2O6S |
| Edoxaban Impurity 22 | 41374-72-5 | C9H10N2O3 |
| Edoxaban Impurity 24 | 2244103-96-4 | C24H30ClN7O5S |
| Edoxaban Impurity 24 | 2024614-21-7 | C21H30ClN5O5 |
| Edoxaban Impurity 25 | 2803372-49-6 | C24H30ClN7O5S |
| Edoxaban Impurity 25 | 1072-98-6 | C5H5ClN2 |
| Edoxaban Impurity 26 | 1255529-33-9 | C21H30ClN5O5 |
| Edoxaban Impurity 28 | 349125-14-0 | C12H8Cl2N4O2 |
| Edoxaban Impurity 28 | 1255529-38-4 | C21H30ClN5O5 |
| Edoxaban Impurity 29 | 480450-71-3 | C17H27N5O2S |
| Edoxaban Impurity 32 | 2081883-53-4 | C14H27N3O3 |
| Edoxaban Impurity 33 | 1461714-66-8 | C15H18N4OS2 |
| Edoxaban Impurity 34 | 1353893-25-0 | C14H27N3O3 |
| Edoxaban Impurity 34 (Oxalate) | 1928729-31-0 | C16H29N3O7 |
| Edoxaban Impurity 35 | 2081883-52-3 | C14H27N3O3 |
